Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Retroscreen Virology Group PLC issues FY 2013 revenue guidance


Monday, 16 Dec 2013 02:00am EST 

Retroscreen Virology Group PLC:Expects to report revenues for the year ending Dec. 31, 2013 in excess of 27.0 million pounds (Year ended Dec. 31, 2012: 14.4 million pounds), significantly ahead of market expectations.Says the company is also continuing to achieve improvements to gross margin and profitability.Says the revenue growth is principally due to the increased number of client engagements and quarantines conducted during 2013, together with the study set-up and volunteer recruitment for a number of new VCM engagements with quarantines due to commence in 2014.FY 2013 revenue of 27.30 million pounds - Thomson Reuters I/B/E/S Estimates. 

Company Quote

250.0
-7.375 -2.87%
24 Oct 2014